tiprankstipranks
Trending News
More News >
ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H (HK:1541)
:1541
Hong Kong Market

ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H (1541) Cash flow

Compare
3 Followers

ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H Cash Flow

HK:1541's free cash flow for Q2 2025 was ¥-131.68M. For the 2025 fiscal year, HK:1541's free cash flow was decreased by ¥231.81M and operating cash flow was ¥-131.12M. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21
Operating Cash Flow
¥ -128.03M¥ -367.55M¥ -238.71M¥ -190.54M
Investing Cash Flow
¥ 37.95M¥ -294.85M¥ 49.00K¥ -108.72M
Financing Cash Flow
¥ 258.93M¥ 331.04M¥ 179.38M¥ 793.03M
End Cash Position
¥ 477.60M¥ 306.98M¥ 635.21M¥ 668.33M
Free Cash Flow
¥ -138.44M¥ -370.25M¥ -261.93M¥ -315.79M
Currency in CNY

ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H Cash Flow